Financials
Financial year 2025
Gross margin
€ 384,828
Profit
Healthy€ 2.3 million
Debts
Low€ 169,282
AdFinitis from Nivelles, company number BE1012280815, closed financial year 2025 with a result of € 2.3 million after tax. For that financial year AdFinitis recorded a gross margin of € 384,828 and equity of € 44.6 million. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on January 27, 2026.
What happened at AdFinitis?
What happened at AdFinitis in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 2.3 million. Source: NBB ↗
- New establishment in Braine-l'Alleud. KBO
- Martial DOLLINGER became a director. NBB
- Start of the company according to the CBE. KBO
In short
Paid € 79,521 in corporate taxes since 2025.
A new publication or filing at AdFinitis? We notify you, reason included.
Follow AdFinitisNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Behind AdFinitis is Martial DOLLINGER. It owns 55% of PHARMA FLEX SA itself.
Directors
According to the 2025 annual accounts
Martial DOLLINGER
Managing director
Also active at: SECOYA Technologies, DOLLIMMO BELGIUM, PHARMA FLEX
since 2024
Establishments
Establishment units
Physical locations of this company
Rue Graham Bell 8
1402 Nivelles
Rue Jean le Meunier 15
1420 Braine-l'Alleud
Active since 7 August 2024
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 6 companies are registered at this address.
PHARMA TECHNOLOGY
€ 26.8 million revenue · 2025
DOLFINANCE
€ 116,272 gross margin · 2025
PHARMA VAT UNIT
DOLLIMMO BELGIUM same network
€ -28,846 gross margin · 2025
PHARMA FLEX same network
€ 2.1 million revenue · 2025
+1 more
Details
- Company number
- 1012.280.815
- VAT number
- BE 1012.280.815
- Registered office
- Rue Graham Bell 8, 1402 Nivelles
- Names & denominations
- AdFinitis
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 7 August 2024
- Peppol
- Active · Active since 27 Mar 2026
- Activities · NACE
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering
Activiteiten van holdings
Overige zakelijke dienstverlening, neg
Holdings